These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27051336)

  • 21. [Safety and efficacy of attenuated Salmonella typhimurium harbouring DNA vaccine against Newcastle disease virus].
    Pan ZM; Jiao XA; Huang JL; Yin YL; Tang LH; Zhang H; Zhang XM; Zhang XR; Liu XF
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):937-41. PubMed ID: 16496707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV.
    Iritani Y; Aoyama S; Takigami S; Hayashi Y; Ogawa R; Yanagida N; Saeki S; Kamogawa K
    Avian Dis; 1991; 35(4):659-61. PubMed ID: 1664717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy.
    Kamiya N; Niikura M; Ono M; Kai C; Matsuura Y; Mikami T
    Virus Res; 1994 Jun; 32(3):373-9. PubMed ID: 8079517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines.
    Maas RA; de Winter MP; Venema S; Oei HL; Claassen IJ
    Vet Q; 2000 Oct; 22(4):223-7. PubMed ID: 11087135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.
    Liu J; Zhu J; Xu H; Li J; Hu Z; Hu S; And XW; Liu X
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28809802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines.
    Maas RA; Komen M; van Diepen M; Oei HL; Claassen IJ
    Vaccine; 2003 Jul; 21(23):3137-42. PubMed ID: 12804840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, characterization, and in ovo vaccination of dextran-spermine nanoparticle DNA vaccine coexpressing the fusion and hemagglutinin genes against Newcastle disease.
    Firouzamandi M; Moeini H; Hosseini SD; Bejo MH; Omar AR; Mehrbod P; El Zowalaty ME; Webster TJ; Ideris A
    Int J Nanomedicine; 2016; 11():259-67. PubMed ID: 26834470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
    Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
    Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The quantitative ELISA for inactivated Newcastle antigen: experience report from an OMCL.
    Motitschke A; Jungbäck C
    Dev Biol (Basel); 2012; 134():55-66. PubMed ID: 22888596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation.
    Xie P; Li Y; Li Y; Liang J; Xiang B; Lin Q; Jin J; Ding C; Xu C; Ren T
    Arch Virol; 2020 Sep; 165(9):1959-1968. PubMed ID: 32519007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
    Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
    J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction of DNA vaccines containing C3d-P29 against Newcastle disease].
    Chu X; Peng J; Weng L; Zhu R; Niu Z
    Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):234-8. PubMed ID: 18438007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of chicken embryos with escape mutants of La Sota Newcastle disease virus induces a protective immune response.
    Mast J; Nanbru C; Decaesstecker M; Lambrecht B; Couvreur B; Meulemans G; van den Berg T
    Vaccine; 2006 Mar; 24(11):1756-65. PubMed ID: 16343701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a novel DNA vaccine candidate targeting F gene of genotype VII Newcastle disease virus and chicken IL-18 delivered by Salmonella.
    Gao X; Xu K; Yang G; Shi C; Huang H; Wang J; Yang W; Liu J; Liu Q; Kang Y; Jiang Y; Wang C
    J Appl Microbiol; 2019 May; 126(5):1362-1372. PubMed ID: 30785663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prokaryotic recombinant hemagglutinin-neuraminidase protein enhances the humoral response and efficacy of commercial Newcastle disease vaccines in chickens.
    Lee JW; Huang JP; Hong LS; Shu SF; Yu C; Chu CY
    Avian Dis; 2010 Mar; 54(1):53-8. PubMed ID: 20408399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of modified NDV F48E9 strain HN gene and in vitro expression of its DNA vaccine].
    He S; Shi X; Wang Y; Wang M; Ran D; Tong G
    Sheng Wu Gong Cheng Xue Bao; 2008 Feb; 24(2):226-31. PubMed ID: 18464605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy.
    Gu M; Liu W; Xu L; Cao Y; Yao C; Hu S; Liu X
    Virol J; 2011 Mar; 8():150. PubMed ID: 21453506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant infectious bursal disease virus expressing Newcastle disease virus (NDV) neutralizing epitope confers partial protection against virulent NDV challenge in chickens.
    Li K; Gao L; Gao H; Qi X; Gao Y; Qin L; Wang Y; Wang X
    Antiviral Res; 2014 Jan; 101():1-11. PubMed ID: 24200519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses.
    Miller PJ; Estevez C; Yu Q; Suarez DL; King DJ
    Avian Dis; 2009 Mar; 53(1):39-49. PubMed ID: 19432002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus.
    Sun HL; Wang YF; Tong GZ; Zhang PJ; Miao DY; Zhi HD; Wang M; Wang M
    Avian Dis; 2008 Mar; 52(1):111-7. PubMed ID: 18459306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.